C, H., CS, C., Y, S., H, C., J, L., Y, H., . . . Z, M. (2024). Digital subtraction angiography-guided pancreatic arterial infusion of GEMOX chemotherapy in advanced pancreatic adenocarcinoma: A phase II, open-label, randomized controlled trial comparing with intravenous chemotherapy. BMC cancer, 24(1), 941. https://doi.org/10.1186/s12885-024-12695-8
Chicago Style (17th ed.) CitationC, Huang, et al. "Digital Subtraction Angiography-guided Pancreatic Arterial Infusion of GEMOX Chemotherapy in Advanced Pancreatic Adenocarcinoma: A Phase II, Open-label, Randomized Controlled Trial Comparing with Intravenous Chemotherapy." BMC Cancer 24, no. 1 (2024): 941. https://doi.org/10.1186/s12885-024-12695-8.
MLA (9th ed.) CitationC, Huang, et al. "Digital Subtraction Angiography-guided Pancreatic Arterial Infusion of GEMOX Chemotherapy in Advanced Pancreatic Adenocarcinoma: A Phase II, Open-label, Randomized Controlled Trial Comparing with Intravenous Chemotherapy." BMC Cancer, vol. 24, no. 1, 2024, p. 941, https://doi.org/10.1186/s12885-024-12695-8.